13. New Guidelines-Recommendations Defer; some treat if viral load is >55,000 / mL >350 Asymptomatic Treat; some defer especially if viral loads < 20,000 / mL 200-349 Asymptomatic Treat < 200 Asymptomatic Treat Any Symptomatic Recommendations CD4 / mcL Category
21. For IDV, monitor for nephrolithisis, UA for crystalluria, increased urine pH Urinalysis If Sx of lactic acidosis associated with NNRTIs Serum Lactate Q3-4 mo, monitor for NNRTIs If elevated at baseline, monitor within 1-2 mo Lipid Profile Q 3-6 mo, more closely for pancreatitis Amylase / Lipase Frequency / Indication Lab Test Q 3-6 mo, more freq for abnl values & elevated LFTs LFTs Q 3-6 mo, Glucose monitoring Q 3-4 mo Serum Chemistries B12 deficiency m neuropathy vs. HAART Tx induced neuropathy Vitamin B12 Q 3-6 mo, more freq with low values or bone marrow toxicities CBC with DIFF Dx, before Tx, 2-8 wks after start of Tx HIV Viral Load Dx, 3-6 mo, response to Tx CD4